Search

everythinglearnresearchcommunity

for

Search:↓

Dimethyl fumarate speeds up wound healing in IL-36Ra deficient mice by reducing NET formation and oxidative stress.

Inhibiting IL-17 and IL-23 improves wound healing in obese, diabetic mice by promoting healing macrophages.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Keratin 17 is important for skin development and may help define skin cell types.

Higher levels of IL-1R1 and hsa-miR-19b-3p may help diagnose and predict alopecia areata severity.

Keratin 17 is crucial for normal hair growth by regulating hair cycle transitions with TNFα.

KRT17 may be a new target for endometrial cancer treatment because it helps cancer cells move and form new blood vessels.

New findings suggest targeting IL-23 could treat psoriasis, skin cells can adapt to new roles, direct conversion of skin cells to blood cells may aid cell therapy, removing certain tumor cells could boost cancer immunotherapy, and melanoma may have many tumorigenic cells, not just cancer stem cells.

PX-12 may help treat psoriasis by blocking inflammation and cell death.

Two new IRAK4-inhibitors effectively reduced skin inflammation and immune response markers in healthy volunteers.

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.

IL-27 can prevent hair loss in alopecia areata.

Proinflammatory fibroblasts and vascular endothelial cells are key in keloid development.

Keratin 6A increases skin inflammation, suggesting it could be a target for treating certain skin diseases.

Treatment with biologic agents can significantly improve psoriasis symptoms, and blood biomarkers could potentially predict individual patient's response to treatment.

IL-9/IL-9R signaling can negatively affect human hair growth and may be a target for treating hair loss conditions.

TEC kinases may help cause inflammation in vitiligo and could be targeted for treatment.

Targeting Keratin 17 may help overcome cancer therapy resistance.

Type 2 cytokines IL-4 and IL-13 increase skin's vulnerability to Staphylococcus aureus, which could be important for treating atopic dermatitis.

Higher levels of MIG and IP-10 may help diagnose and monitor Alopecia Areata.

Certain immune cells in atopic dermatitis skin could be targeted for treatment.

IL-15 helps hair grow longer and stronger by extending the growth phase and reducing cell death.

ILC1-like cells can cause alopecia areata by affecting hair follicles.

Different γδ T cell types have unique roles in causing alopecia areata.

SIG-1451 could be a promising new treatment for atopic dermatitis.

Higher levels of IL-1a and IL-1RA were found in severe alopecia areata cases.

Laminin-511 is involved in psoriasis development and can be regulated by cannabinoid receptor type 1.

ILC1-like cells can cause alopecia areata by attacking hair follicles.

An elderly man's hair grew back after treatment with secukinumab, possibly due to reduced scalp inflammation or the medication's direct effects.